Exagen (XGN)

• Market cap: $66.9M
• 1 day: -6.4%
• 5 days: -9.45%
• 1 month: -18.48%
• 3 months: -58.07%
• 6 months: -71.78%
• Year to date: -53.97%
• 1 year: -24.66%
• 5 years: -85.46%
• 10 years: -85.04%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Employees: 220